r The mechanisms affecting recruitment patterns of postganglionic sympathetic nerves remain unclear. The divergent and convergent preganglionic innervation patterns of postganglionic neurons and the presence of differently sized postganglionic nerves suggest that the ganglia may participate in modifying the discharge patterns of single sympathetic postganglionic neurons innervating the skeletal muscle circulation.
Introduction
The ganglia determine the extent to which the sympathetic nervous system communicates central intentions to the peripheral vasculature supplying skeletal muscle (Gibbins & Morris, 2006) . The ganglia participate in spatial amplification of efferent sympathetic outflow through synaptic divergence of a distribution of primary 'strong' synapses (Jänig & Häbler, 2003; McLachlan, 2003) . Also, patterns of pre-to-post ganglionic convergent innervation have been observed in rodent and amphibian models (Rimmer & Horn, 2010; Springer et al. 2015) . As the degree of convergence appears to scale with neuron size in mammals (Purves & Lichtman, 1985; Purves et al. 1986) , it would be expected to add greater complexity to the temporal and spatial summation of excitatory post-synaptic potentials (EPSP).
The synchronization of differently sized action potentials (APs) into bursts of activity represents a fundamental characteristic of sympathetic activity, readily observed in neurograms of sympathetic nerve activity directed towards the vasculature of skeletal muscle (muscle sympathetic nerve activity; MSNA). Furthermore, multi-unit and single-unit recordings of axonal firing patterns within MSNA bursts have revealed additional layers of complexity regarding communication strategies contained within the sympathetic neural signal in humans (Shoemaker et al. 2014 Macefield & Wallin, 2018) . For instance, under baseline conditions, recruited axons fire with relatively low probability (e.g. 21% of cardiac cycles; Macefield et al. 1994) . In addition, multi-unit AP recordings show that as a population, firing probabilities of differently sized APs (probably not the same axon) tend to vary with AP size in an inverted 'U' manner, such that the smallest AP clusters and largest AP clusters express low within-burst probabilities whereas moderately sized AP clusters are expressed frequently, with some occurring in every burst (Steinback et al. 2010; Salmanpour & Shoemaker, 2012; Limberg et al. 2018) . Furthermore, acute homeostatic challenges (e.g. apnoeic, metabolic and orthostatic stress) reveal an orderly recruitment strategy where the sympathetic system expresses options of increasing the firing probability of already-active APs and, in high stress, recruitment of a subpopulation of latent, larger and faster-conducting APs (Steinback et al. 2010; Salmanpour et al. 2011a; Badrov et al. 2016b) . Further, the timing of a recruited AP may be modified by synaptic delays (Fagius et al. 1987; Wallin et al. 1994 ) -a feature which we hypothesize to be mediated, in part, by perceptual mechanisms (Salmanpour et al. 2011b; Badrov et al. 2015; Klassen et al. 2018) . These ordered patterns of postganglionic AP behaviour and recruitment imply heterogeneous regulation of sympathetic neurons. However, the neural sites within reflex arcs and/or descending sympathetic pathways that exert influence over these discharge patterns remain uncertain.
Even at the level of the integrated sympathetic signal, the neural circuitry involved in MSNA control remains unclear. While the brainstem network forming the arterial baroreflex represents perhaps the most thoroughly studied site of sympathetic regulation, contributing to the pulse-synchronous 'bursty' nature of the signal (Spyer, 1994) , evidence also points towards baroreflex-independent pathways as a source of MSNA patterns, especially fluctuations in burst amplitude, which are dependent on AP content (Malpas, 1995; Kienbaum et al. 2001) . For example, supra-medullary sites are involved in regulating sympathetic outflow (Kimmerly et al. 2007; Henderson et al. 2012; Shoemaker & Goswami, 2015; Barman & Yates, 2017; Taylor et al. 2018) , including the variability in burst size (Tank et al. 2003) . To date, however, few investigations have studied the contribution of other, non-baroreflex sites within the sympathetic system, to patterns of sympathetic discharge, such as spinal (Stjernberg et al. 1986) or ganglionic mechanisms.
This study tested the hypothesis that the paravertebral ganglia contribute to ordered patterns of sympathetic AP discharge at baseline in humans. To address this hypothesis, we examined the impact of paravertebral ganglionic blockade (via intravenous trimethaphan camsylate) on multifibre recordings with microneurography at the peroneal nerve in female participants.
Methods

Ethical approval
All procedures were approved by the Mayo Clinic Institutional Review Board (No. 09-008548) and the study conformed to the standards set by the Declaration of Helsinki, except for registration in a database. All participants provided written, informed consent after receiving verbal and written instructions outlining the experimental protocol.
Participants
This study evaluated data from seven healthy females (37 ± 5 years, 165 ± 2 cm, 60 ± 4 kg, 22 ± 1 kg m −2 , 25 ± 3% body fat). On a separate day prior to the testing session, participants performed health screening to determine that all fitted the study's inclusion/exclusion criteria: non-smoker, systolic blood pressure (BP) <150 mmHg, diastolic BP <95 mmHg, body mass index <30 kg m −2 , and no history of diabetes or cardiovascular diseases. All participants provided a negative pregnancy test result within 48 h. Pre-menopausal women (n = 5) were tested in the early follicular stage of the menstrual cycle (days 2-6 of menses) or the placebo phase for young women on oral contraceptives (n = 2, participant identifiers TM59 and TM63, both taking levonorgestrel and ethinyl estradiol). No other participants were taking medications. Two participants were post-menopausal (n = 2, participant identifiers TM32 and TM50, 7 and 6 years since last menses, respectively).
Experimental procedures
Participants arrived at the laboratory after an overnight fast and refraining from heavy exercise, caffeine and alcohol for 24 h before the study. Participants assumed the supine position for instrumentation and data collection. After local anaesthetic with 2% lidocaine, a 5 cm 20-gauge arterial catheter was placed in the brachial artery of the non-dominant arm, using aseptic technique. The catheter was connected to a pressure transducer, positioned at heart level to record continuous arterial BP. A three-lead electrocardiogram (ECG) recorded continuous heart rate (HR).
Research personnel placed an intravenous catheter in the contralateral arm for drug infusion.
Experimental design
Data were collected during baseline and the trimethaphan camsylate infusion (1-7 mg min −1 ; Cambridge Laboratories, Wallsend, UK). Trimethaphan infusion rate was adjusted over time, though this varied across participants. During the trimethaphan infusion, once cessation of integrated MSNA burst activity occurred, participants were instructed to perform a 20 s Valsalva's manoeuvre with an expiratory mouth pressure of 40 mmHg. After discontinuation of the study and de-instrumentation, subjects remained in the Clinical Research Unit for ࣙ2 h for observation.
Data analysis was conducted for four study conditions: (1) 5 min baseline (309 ± 28 s), (2) minute-by-minute of the trimethaphan infusion where integrated sympathetic bursts were visible and AP analysis could be performed (note that the last 'minute' was 89 ± 17 s to provide a suitable number of bursts for analysis), (3) 2 min (120 ± 0 s) of the trimethaphan infusion where sympathetic bursts were not visible, and (4) a Valsalva's manoeuvre performed during the trimethaphan infusion where sympathetic bursts were not visible (23 ± 7 s).
Experimental measures and analysis
Efferent multiunit MSNA was measured from postganglionic C-fibres in the peroneal nerve by microneurography (Hagbarth & Vallbo, 1968) as detailed recently . Integrated bursts of MSNA were analysed if they were pulse-synchronous, had a signal-to-noise ratio of at least 2:1 relative to the previous period of neural silence, and expressed characteristic rising and falling slopes. MSNA bursts were inspected for consistent amplitude to rule out shifts in microelectrode position.
At the integrated level, sympathetic activity was quantified as burst frequency (bursts min −1 ) and burst incidence (bursts per 100 beats). Burst amplitude (AU) was measured in volts and normalized to the max. burst amplitude at baseline, which was given a value of 100. Total MSNA (AU min −1 ) was measured as the product of burst frequency and amplitude. Sympathetic burst latency was measured as the mean time interval (s) from the preceding ECG R-wave to the peak of the corresponding MSNA burst in the integrated neurogram (Fagius & Wallin, 1980) . Postganglionic sympathetic APs were detected and extracted from the filtered raw MSNA signal using a continuous wavelet transform, which has been described in detail previously . At baseline and during trimethaphan infusion where integrated bursts were visible, APs were only extracted if they occurred J Physiol 596.18 within an integrated burst (i.e. 0.8 s around the peak of the burst). Alternatively, during trimethaphan infusion where integrated bursts were no longer visible, any AP that occurred was extracted. With both techniques, extracted APs were ordered based on peak-to-peak amplitude, and histogram analysis was performed to separate APs into amplitude-based clusters. Cluster bin widths for baseline data were automatically defined based on Scott's rule, which balanced bin width, data bias and variance to minimize the integrated mean square error (Scott, 1979) . Thus, the number of total clusters at baseline varied by participant. AP data collected during the different periods of the trimethaphan infusion (i.e. MSNA bursting period, non-bursting period and Valsalva's manoeuvre) were normalized to baseline for each participant to ensure that bin width, maximum bin centre, and the total number of bins would be identical across conditions. APs that were not detected during trimethaphan were considered de-recruited from baseline. The signal-to-noise ratio was determined as the amplitude of the negative peak of the mean AP over the standard deviation of the background noise. Based on our previous simulations, the signal-to-noise ratio of the multi-unit AP signal obtained at baseline (4.2 ± 0.7) and during trimethaphan (4.2 ± 0.5) was expected to produce a correct detection rate of >90% and a false positive rate of <3% .
AP indices included AP frequency (APs min −1 ), incidence (APs per 100 beats), and the mean AP content per integrated burst. Also, the number of total clusters detected and the number of active clusters per integrated burst were assessed. AP latency was determined as the time delay from the R-wave of the preceding cardiac cycle to the negative peak of the AP (Salmanpour et al. 2011b) . AP cluster latency was determined as the mean latency of all APs within a cluster. AP cluster firing probability distributions were constructed to evaluate the firing probability of each sympathetic AP cluster at baseline and the final minute of bursting activity during the trimethaphan infusion. To do so, we divided the number of times an AP cluster fired by the total number of bursts that occurred in a given condition, and multiplied by 100 to give a percentage. A probability of 100% indicates that the cluster fired once in every integrated burst, whereas a probability of less than, or greater than, 100% indicates that the cluster was not active in every burst, or occasionally fired more than once per burst, respectively.
HR and BP were collected at 1000 Hz. The mean values for HR and mean arterial pressure (MAP) were calculated for all conditions. All signals were sampled using PowerLab (ADInstruments; Castle Hill, New South Wales, Australia) and stored on a computer for subsequent analysis. Researchers were not blinded during analysis.
Statistical analyses
This study tested the hypothesis that the ganglia contribute to patterns of postganglionic sympathetic AP discharge at baseline in humans. All data are presented as the mean ± SD. Due to the inter-individual variability in magnitude and time course of the nicotinic blockade, minute-by-minute changes in all sympathetic indices with trimethaphan infusion were not evaluated statistically. Accordingly, Student's paired sample t test was employed to assess differences between: (1) baseline versus the last minute of bursting activity during the trimethaphan infusion, and (2) the non-bursting period of the trimethaphan infusion versus the responses to Valsalva's manoeuvre. For AP clusters expressing trimethaphan resistance, a repeated-measures analysis of variance (RMANOVA) assessed changes in AP incidence across baseline, the last minute of the trimethaphan infusion with visible bursts, and the period of the trimethaphan infusion without visible bursts. Linear regression was performed to assess the relationship among indices of sympathetic outflow at the integrated and AP level. Statistical analysis was performed using SPSS Statistics (v 23, IBM Corp., Armonk, NY, USA). Tests were two tailed with α = 0.05. Each unique symbol represents the same participant's data across figures depicting individual data.
Results
Figure 1 illustrates one participant's response to trimethaphan infusion, particularly the reductions in integrated bursting activity ( Fig. 1Aa ) and the discharge patterns of sympathetic AP clusters during drug infusion (Fig. 1Ab) . These results compare baseline to the last minute of visible bursting activity that was suitable for AP analysis during the trimethaphan infusion, unless specified otherwise. The mean time from infusion start to burst cessation was 523 ± 242 s. At this time, the infusion rate was 2 ± 1 mg min −1 . Trimethaphan infusion was associated with an increase in HR (baseline versus final minute of trimethaphan condition with MSNA bursts: 57 ± 11 to 66 ± 12 bpm, P < 0.01) and a reduction in MAP (97 ± 7 to 90 ± 7 mmHg, P < 0.01) compared to baseline (Fig. 2) . Relative to baseline, trimethaphan elicited a progressive reduction in total sympathetic outflow (833 ± 458 to 157 ± 120 AU min −1 , P < 0.01), characterized by fewer integrated bursts (burst frequency: 17 ± 9 to 5 ± 4 bursts min −1 , P = 0.01; burst incidence: 30 ± 14 to 9 ± 8 bursts (100 beats) −1 , P < 0.01) with decaying amplitude (49 ± 3 to 31 ± 3 AU, P < 0.01) (Fig. 3) . Underlying trimethaphan-mediated attenuations in the integrated MSNA signal were reductions in AP frequency (104 ± 65 to 17 ± 17 AP min −1 , P = 0.01) and incidence (186 ± 101 to 29 ± 31 AP (100 beats) −1 , P < 0.01) as well as attenuated AP content per integrated burst (7 ± 2 to 3 ± 1 AP burst −1 , P < 0.01) (Fig. 4) . When detected APs were binned according to peak-to-peak amplitude, the total number of active AP clusters was reduced with trimethaphan (14 ± 3 to 8 ± 2, P < 0.01), resulting in fewer unique clusters firing per burst (4 ± 1 to 3 ± 1 clusters burst −1 , P < 0.01) (Fig. 4) . Trimethaphan infusion did not affect the latency of MSNA bursts (1.25 ± 0.05 to 1.22 ± 0.05) or APs (1.18 ± 0.06 to 1.16 ± 0.07 s) (both P > 0.12).
Closer analysis of the within-burst AP cluster firing patterns revealed a distribution of firing probabilities that scaled to AP cluster size in an inverted 'U' manner.
At baseline, moderately sized clusters fired with high probability (i.e. approximately every burst), whereas the smallest AP clusters and largest AP clusters expressed low within-burst probabilities across all participants. In the last minute of visible bursting activity during the trimethaphan infusion, participants demonstrated a reduction in the firing probability of the majority of AP clusters with the largest AP clusters (range: 4-10 largest clusters) ceasing to fire, moderately sized cluster firing displaying moderate declines in probability, and generally no change in the activity of smaller clusters. Firing probability distributions for each participant ( 
Figure 1. Representative sympathetic neural and hemodynamic recordings during trimethaphan infusion in one individual
Aa and Ba, representative recordings of heart rate (HR) and blood pressure (BP), and the integrated muscle sympathetic nerve activity (MSNA) neurogram from one individual during the trimethaphan infusion where integrated MSNA bursts were detected (Aa) and during the trimethaphan infusion where integrated MSNA bursts were no longer visible (Ba). Ab and Bb, the associated pattern of action potential (AP) activity during the trimethaphan infusion where integrated MSNA bursts were detected (Ab) and during the trimethaphan infusion where integrated MSNA bursts were no longer visible (Bb). Ab, occurrence of APs within each burst as a function of their cluster (illustrated along the left). Cluster refers to all APs of similar morphology. Bb, because no bursts were detected, activity of all APs was extracted and presented as a function of their cluster. APs extracted during trimethaphan infusion were normalized to baseline.
J Physiol 596.18
enable visualization of the between-subject variability in active cluster number and the extent of large cluster de-recruitment with trimethaphan, whereas the group averaged normalized distributions (Fig. 5B) show a similar pattern of reduced cluster firing probability with trimethaphan but allow statistical comparisons between baseline and trimethaphan. At baseline, AP cluster latency decreased as a function of normalized cluster number (i.e. as peak-to-peak AP cluster and heart rate (D) at baseline (BSL) and during each minute of the trimethaphan infusion where integrated sympathetic bursts were visible Minute-by-minute data are presented with line graphs with each unique symbol representing the same participant's data across figures depicting individual data. Mean ± SD for BSL and the last minute of detectable integrated sympathetic bursting activity during the trimethaphan infusion (Last min) are represented by half-filled circles and error bars. DBP, diastolic blood pressure; MAP, mean arterial pressure; HR, heart rate; SBP, systolic blood pressure.
* Significantly different from Last min, P < 0.01.
amplitude increased) (R 2 = 0.67, P < 0.01). Because trimethaphan abolished the firing of the largest clusters, the AP cluster latency-size relationship was examined for the entire condition (i.e. from infusion start until the last minute of visible bursting activity) and was not restricted to the final minute of bursting activity. Here, the same general pattern was observed, but did not reach significance (R 2 = 0.28, P = 0.11). The mean AP cluster latency-size responses were fitted using an exponential decay function (Fig. 6 ). These relationships support the concept that AP cluster size scaled to the diameter of sympathetic C-fibres within the recording field of the micro-electrode.
At baseline, linear regression indicated moderateto-strong relationships between relative integrated burst size and the number of APs per burst (y = (0.14 ± 0.05)x -(0.37 ± 0.55), r 2 = 0.57 ± 0.17, all P < 0.01), normalized integrated burst amplitude and AP clusters per burst (y = (0.05 ± 0.02)x + (1.64 ± 0.31), r 2 = 0.37 ± 0.21, all P < 0.01), and the number of AP clusters per burst and the number of APs per burst (y = (0.33 ± 0.05)x + (1.78 ± 0.13), r 2 = 0.60 ± 0.13, all P < 0.01). In the last minute of visible bursting activity during the trimethaphan infusion, the same fundamental relationships were observed, though these were not significant in all participants (integrated burst size vs. the number of APs per burst: y = (0.12 ± 0.08)x + (0.02 ± 3.3), r 2 = 0.30 ± 0.25, P < 0.05 in n = 3 of 7 participants, normalized integrated burst amplitude vs. AP clusters per burst: y = (0.04 ± 0.05)x + (1.65 ± 2.0), r 2 = 0.19 ± 0.16, P < 0.05 in n = 2 of 7 participants, and the number of AP clusters per burst vs. the number of APs per burst: y = (0.36 ± 0.25)x + (1.28 ± 0.62), r 2 = 0.56 ± 0.33, P < 0.05 in n = 5 of 7 participants). Figure 7 illustrates these relationships for one participant.
During the period of the trimethaphan infusion where integrated bursts were no longer visible (120 ± 0 s, 80 ± 6 bpm, MAP: 87 ± 12 mmHg), we observed the discharge of a population of trimethaphan-resistant APs. In all seven individuals, these APs were the smallest 6 ± 2 sympathetic AP clusters (range: 4-8 AP clusters) present at baseline, firing in an asynchronous pattern (i.e. visual inspection showed no apparent baroreflex-mediated pulse rhythmicity) with a frequency of 38 ± 32 AP min −1 (49 ± 41 AP (100 beats) −1 ) ( Fig. 1Ba and b) . Compared to baseline (118 ± 61 APs (100 beats) −1 ), trimethaphan-resistant clusters (i.e. not clusters de-recruited by trimethaphan) demonstrated reduced incidence in the last minute of visible bursts during trimethaphan infusion (26 ± 24 APs (100 beats) −1 , simple-effects paired t test: P < 0.01) as well as during the period of the trimethaphan infusion without visible bursts (49 ± 41 APs (100 beats) −1 , simple-effects paired t test: P: < 0.05; RMANOVA: P < 0.05). There were no differences in the incidence of trimethaphan-resistant clusters between the final minute of visible bursts during trimethaphan and the period of the trimethaphan without visible bursts (simple-effects paired t test: P > 0.3).
While trimethaphan infusion continued, research personnel instructed participants to perform a Valsalva's manoeuvre. Valsalva's manoeuvre (28 ± 9 and 24 ± 7 mmHg reduction in MAP and pulse pressure, respectively, from baseline to phase II, both P < 0.01) failed to elicit integrated MSNA bursts in six of seven participants. When examining the data from the six individuals with absent MSNA responses to . Sympathetic action potential cluster probability distributions at baseline and during trimethaphan infusion A, sympathetic action potential (AP) cluster probability distributions for each participant at baseline (BSL) and the last minute of visible integrated sympathetic bursting activity during the trimethaphan infusion (TM Last min). B, group averaged sympathetic AP probability distributions for BSL and TM Last min with AP clusters normalized to the largest cluster at baseline. For both individual and group averaged figures, a probability of 100% indicates that the cluster fired once in every integrated burst, whereas a probability of less than, or greater than,100% indicates that the cluster was not active in every burst, or occasionally fired more than once per burst, respectively. * Significantly different from TM Last min within cluster, P < 0.01.
Valsalva's manoeuvre only, compared to the period of the trimethaphan infusion where trimethaphan-resistant APs were observed, but integrated bursts were not visible (38 ± 32 AP min −1 ; 49 ± 41 APs (100 beats) −1 ), the Valsalva's manoeuvre did not increase the firing frequency of trimethaphan-resistant APs (49 ± 32 AP min −1 , 60 ± 42 AP (100 beats) −1 ; both P > 0.30, both Cohen's d effect size ࣘ 0.21, n = 6), nor were additional larger APs recruited (6 ± 1 clusters, P = 0.30, n = 6).
Discussion
The current study provides new evidence regarding the role of the paravertebral ganglia in the emission patterns of sympathetic postganglionic nerves directed towards the skeletal muscle vasculature. First, we demonstrate that blockade of nicotinic receptors at the ganglia elicited an ordered pattern of AP de-recruitment beginning with larger APs that fire with lower probability under baseline conditions, followed by the progressive decreased probability of smaller APs. Second, following trimethaphan-mediated cessation of integrated MSNA bursts, small AP clusters persisted to fire in an asynchronous pattern. Also, Valsalva's manoeuvre did not increase the firing rate of these persistent AP clusters, or elicit recruitment of larger APs that had previously been inhibited by trimethaphan. We interpret these observations to suggest: (1) the paravertebral ganglia contribute to the heterogeneity in the firing probabilities of differently sized postganglionic sympathetic APs active under baseline conditions, and (2) the presence of non-synchronized APs that express resistance to blockade with trimethaphan. Variations in integrated burst amplitude reflect the number and size of APs synchronized to fire at about the same time (Ninomiya et al. 1993; Salmanpour et al. 2011a) . Varying sized APs express a heterogeneity of firing probabilities, such that, compared to moderately sized APs, larger and smaller APs contribute to considerably fewer bursts, while a subpopulation of even larger APs are recruited during severe stress (Steinback et al. 2010; Salmanpour & Shoemaker, 2012) . Focusing on baseline data only, ganglionic blockade in the current study produced an ordered pattern of de-recruitment where larger APs were inhibited, reducing burst size, followed by blockade of most small AP clusters, rendering integrated bursts undetectable. As these data were collected as part of a larger study, waiting for metabolism of trimethaphan and subsequent return of the MSNA signal was not possible. Therefore, we cannot rule out the possibility that reductions in burst size and AP cluster firing as well as the cessation of bursts following blockade were attributable to changes in microelectrode position. However, this is unlikely given the observation that small AP clusters were present through the entire study and no changes in background signal intensity were observed.
Whereas trimethaphan exerted early effects on larger AP clusters, our previous studies suggest that these clusters must express a higher threshold for recruitment (Steinback et al. 2010) . Also, based on replicated evidence that larger AP clusters express faster conduction velocity (Salmanpour et al. 2011a; Klassen et al. 2018) , we expect that larger AP clusters reflect neurons with larger axons. Together, these observations indicate that the larger AP clusters express a higher threshold for recruitment and also a higher sensitivity for de-recruitment through a post-junctional nicotinic mechanism. These data indicate that the ganglia participate in the recruitment probability of larger AP clusters. Furthermore, the observation that medium-sized APs exhibited moderate reductions in firing probability but were still active in the final minute of MSNA bursting during trimethaphan infusion suggests that the ganglia express some differential organization for postganglionic recruitment by neuron size.
We speculate that this pattern of recruitment and de-recruitment may reflect a scaling of preganglionic J Physiol 596.18 synaptic input strength at the ganglia. However, the neural mechanisms mediating such a preganglionic effect are not known. To our knowledge, beyond the investigations using ganglionic blockade as a model of the circulation under negligible autonomic control (Jones et al. 2001; Marinos et al. 2017) or delineating the origins of the integrated sympathetic signal (Delius et al. 1972) , no previous study has examined the role of the ganglia in human sympathetic AP discharge. While earlier studies in animals may provide some insight to the mechanisms (e.g. ganglionic convergence) contributing to the present observations, the focus on compound APs or single-unit recordings in these investigations (Obrador & Odoriz, 1936; Karila & Horn, 2000; Horn & Kullmann, 2007; Bratton et al. 2010; Rimmer & Horn, 2010; Springer et al. 2015) prevents direct comparisons with the current observations. Interestingly, compared to moderately sized APs that express strong baroreflex modulation, larger APs are weakly associated with fluctuations in diastolic BP, suggesting that additional sites of control beyond the arterial baroreflex participate in the regulation of the larger, low-probability APs (Salmanpour & Shoemaker, 2012) . Similar conclusions have been drawn based on the observation that burst occurrence, but not size, was related to diastolic BP in humans (Kienbaum et al. 2001) , causing this latter group and others (Malpas, 1995) to speculate on sites outside of the baroreflex pathways that affect burst size (analogous to large AP cluster recruitment). Consistent with this idea, both magnetic resonance imaging and electroencephalographic studies suggest the involvement of neural regions beyond the baroreflex brainstem nuclei in the regulation of MSNA (Tank et al. 2003; Kimmerly et al. 2005; Henderson et al. 2012; Kobuch et al. 2018) . In this conjecture, the strength of preganglionic inputs to postganglionic neurons possessing larger diameter axons would reflect a subpopulation of descending neural signals from higher cortical sites that are not under direct baroreflex regulation.
The second major observation of the current study was a population of smaller AP clusters that persisted to fire in an asynchronous manner, without consistent baroreflex rhythmicity, following blockade of nicotinic receptors. To our knowledge, this phenomenon has not been reported previously in humans. While these APs may not have been sympathetic, this is unlikely as they exhibited similar morphological characteristics to the smaller AP clusters that were synchronized to fire within bursts at baseline and during the trimethaphan infusion Representative relationships among indices of sympathetic outflow at both the integrated and action potential level during baseline and the trimethaphan infusion A, the number of sympathetic action potentials (APs) per burst as a function of relative integrated burst amplitude (normalized to the largest burst at baseline and during the trimethaphan infusion) at baseline (Aa) and the last minute of detectable integrated sympathetic bursting activity during the trimethaphan infusion (Ab). B, the number of unique sympathetic AP clusters per burst as a function of relative integrated burst amplitude at baseline (Ba) and the last minute of detectable integrated sympathetic bursting activity during the trimethaphan infusion (Bb). C, the number of unique AP clusters per sympathetic burst as a function of the number of APs per burst at baseline (Ca) and the last minute of detectable integrated sympathetic bursting activity during the trimethaphan infusion (Cb). Data presented are from one individual.
when integrated bursts were visible. This observation also suggests that these clusters did not represent a new population of APs recruited following trimethaphan. Also, an incomplete ganglionic blockade likely did not produce these APs as, in six of seven individuals, Valsalva's manoeuvre performed during the non-bursting period of trimethaphan infusion failed to elicit the recruitment of larger AP clusters or integrated bursts (Salmanpour et al. 2011b) . From these data, we surmise that they represent spontaneous firing of postganglionic axons that normally receive cardiac entrainment via descending baroreflex inputs and/or are controlled by non-nicotinic synaptic mechanisms at the human paravertebral ganglia. Previous studies have documented spontaneous neuronal activity within the medullary sites governing sympathetic discharge (Dampney, 1994) and while this evidence raises the possibility of spontaneous postganglionic spiking, this idea has not been tested. Alternatively, detailed studies in feline and rodent models showed persistent postganglionic activity during nicotinic blockade, illustrating the contribution of non-nicotinic mechanisms to ganglionic signalling (Volle, 1966; Hoffmeister et al. 1978; Jänig et al. 1983) . Also, ganglionic exposure to muscarinic agonists appears to enhance postganglionic nerve activity across several studies (Volle, 1966; Brown et al. 1980) . Janig et al. (1983) further showed that chemoreflex-induced discharge was evident in some, but not all postganglionic neurons during combined nicotinic and muscarinic (atropine) blockade. In the bullfrog, peptide neurotransmitters (including substance P and a peptide resembling luteinizing hormone releasing hormone) contribute to postganglionic EPSPs (Jan & Jan, 1982) . Thus, the most direct explanation of the trimethaphan-resistant AP clusters in the current observations is that they represent a population of neurons with non-nicotinic synaptic mechanisms.
The purpose of non-nicotinic ganglionic neurotransmission remains unclear. This feature does highlight the complex nature of sympathetic neuronal recruitment. Interestingly, repetitive preganglionic nerve stimulation exposes two phases of postganglionic activity in vertebrates: rapid onset, high-frequency discharge mediated by nicotinic receptor actions, and a delayed, low-frequency firing pattern evoked by muscarinic and peptidergic mechanisms (Volle, 1966; Jan & Jan, 1982; Jänig et al. 1983) . The purpose and mechanism(s) supporting the trimethaphan resistance of the smallest AP clusters remain unknown, although the observation may be consistent with the conjecture that the ganglia also participate in axonal size-related recruitment patterns. It can be noted, however, that baroreflex unloading via mild (Millar et al. 2013 ) and moderate-to-severe lower body suction (Salmanpour et al. 2011a; Badrov et al. 2015) , or sodium nitroprusside infusion (Limberg et al. 2018) , results in a paradoxical decrease in the firing of some APs including smaller clusters, supporting the notion that complex mechanisms may regulate small AP patterns.
An additional explanation for the trimethaphanresistant AP clusters is that they do not represent sympathetic C-fibre spiking. We believe this scenario is improbable for three reasons. First, they likely were not produced by sensory axons sensitive to metabolite accumulation, stretch or pain because participants remained still, abstained from exercise 24 h prior to testing, and did not report any discomfort throughout the protocol. Second, trimethaphan-resistant APs were unlikely to represent Type I/II proprioceptive fibre activity, as the myelination of these nerves produces wider APs with prominent positive-going depolarization (Vallbo et al. 1979; Macefield & Knellwolf, 2018) , which are distinct from the sympathetic C-fibre APs detected by the wavelet model used here . Third, we do not suspect that these APs represent false positive detections by the wavelet de-noising method because the signal-to-noise ratio for these APs in the trimethaphan period was 4.2 ± 0.7, a high level that produces a false detection rate of <3% .
There are some methodological considerations for the present study. First, this study did not employ a randomized, placebo control arm alongside the trimethaphan condition. However, in healthy individuals under normal conditions of supine rest, complete abolition of MSNA bursts during protracted periods of falling BP would be highly unlikely. Second, this investigation only studied pre-and post-menopausal females. Both sex and female reproductive hormones are known to affect resting sympathetic outflow as well as total MSNA responses to diverse forms of physiological stress (Shoemaker et al. 2001; . However, these recruitment strategies appear to be fundamental properties of the human sympathetic nervous system (Shoemaker et al. 2014; Macefield & Wallin, 2018) that are simply modified by sex hormones, age and/or health status (Macefield et al. 1999; Badrov et al. 2016a) . Consistent with this notion, the two post-menopausal participants (participant identifiers TM32 and TM50) exhibited greater baseline MSNA (due to a burst incidence mechanism rather than the AP content per burst) than pre-menopausal females (TM32, TM50 vs. pre-menopausal mean ± SD: 44, 46 vs. 24 ± 12 bursts (100 beats) −1 ; 245, 339 vs. 144 ± 80 AP (100 beats) −1 ; 6, 8 vs. 6 ± 2 AP burst −1 ). Despite the larger effect of trimethaphan on MSNA burst incidence in post-menopausal females versus pre-menopausal counterparts ( 39, 37 vs. 15 ± 3 bursts (100 beats) −1 , 231, 319 vs. 110 ± 51 AP (100 beats) −1 , 3, 5 vs. 3 ± 1 APs burst −1 ), the ordered pattern of trimethaphan-mediated AP de-recruitment was consistent between groups (Fig. 5A) . Third, Valsalva's manoeuvre was used to test adequacy of the blockade based clinically on heart and BP responses. We recognize J Physiol 596.18 that additional manoeuvres before blockade would have enabled a prospective analysis of reflex AP recruitment as well. Nonetheless, Valsalva's manoeuvre produces a robust AP recruitment stimulus under baseline conditions in healthy individuals (Shoemaker et al. 2003; Salmanpour et al. 2011b) such that the lack of any recruitment post-blockade indicates a severe impairment of the ganglionic sympathetic transmission.
Conclusions
The current study provides new evidence regarding the role of the paravertebral ganglia in human MSNA regulation. Specifically, the organization of the ganglia may contribute, in part, to the distribution of firing probabilities exhibited by differently sized APs at rest and the recruitment of previously silent, larger and faster-conducting sympathetic neurons during homeostatic stress. Interestingly, our observations also suggest that a population of postganglionic neurons with non-nicotinic synaptic mechanisms may exist within the human sympathetic nervous system. These findings offer new information regarding the neural sites which regulate sympathetic emission patterns fundamental to the maintenance of homeostasis and may contribute to chronic adaptations in sympathetic discharge in ageing and disease.
